Functional connectivity change of brain default mode network in breast cancer patients after chemotherapy

Neuroradiology. 2016 Sep;58(9):921-8. doi: 10.1007/s00234-016-1708-8. Epub 2016 Jun 9.

Abstract

Introduction: Complaint about attention disorders is common among breast cancer patients who have undergone chemotherapy, which may be associated with the default mode network (DMN). To validate this hypothesis, we investigated the DMN functional connectivity (FC) change and its relationship with the attention function in breast cancer patients (BC) using resting-state functional magnetic resonance imaging (rs-fMRI).

Methods: Twenty-two BC treated with chemotherapy and 22 healthy controls (HC) were recruited into this study. The FC between the DMN's hubs and regions of the dorsal medial prefrontal cortex (dMPFC) and medial temporal lobe (MTL) subsystems was respectively calculated for each participant.

Results: The statistical result showed significantly lower connectivity in dMPFC and MTL subsystems in the BC group. In addition, the partial correlation analysis result indicated that the low connectivity of some brain regions in MTL subsystem was correlated with attention dysfunction following BC chemotherapy.

Conclusion: These results suggest that the functional disconnection in MTL subsystem of the DMN may have association with attention function of BC after chemotherapy.

Keywords: Attention deficit; Breast cancer; Chemotherapy; Cognitive impairment; Default mode network.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Attention / drug effects*
  • Brain / drug effects*
  • Brain / physiopathology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / physiopathology*
  • Connectome / methods
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Nerve Net / drug effects
  • Nerve Net / physiopathology
  • Rest
  • Taxoids / administration & dosage
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Taxoids
  • Doxorubicin
  • Cyclophosphamide

Supplementary concepts

  • TAC protocol